Know Cancer

or
forgot password
  • cancer clinical trials in washington

  • S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
    Providence Centralia Hospital

    Trial Locations
    Providence Centralia Hospital
    St. Francis Hospital
    Columbia Basin Hematology
    St. Clare Hospital
    Providence St. Peter Hospital Regional Cancer Center
    Good Samaritan Cancer Center
    Fred Hutchinson Cancer Research Center
    Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
    University Cancer Center at University of Washington Medical Center
    Harborview Medical Center
    Group Health Central Hospital
    Polyclinic First Hill
    Cancer Care Northwest - Spokane South
    MultiCare Regional Cancer Center at Tacoma General Hospital
    CCOP - Northwest
    Madigan Army Medical Center - Tacoma
    Allenmore Hospital
    Franciscan Cancer Center at St. Joseph Medical Center
    Leukemia
    Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
    Providence Cancer Center at Sacred Heart Medical Center

    Trial Locations
    Providence Cancer Center at Sacred Heart Medical Center
    Madigan Army Medical Center - Tacoma
    Brain Tumor, Central Nervous System Tumor
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    Fred Hutchinson Cancer Research Center

    Trial Locations
    Fred Hutchinson Cancer Research Center
    Children's Hospital and Regional Medical Center - Seattle
    Group Health Central Hospital
    Deaconess Medical Center
    Madigan Army Medical Center
    Mary Bridge Children's Hospital and Health Center
    Kidney Cancer
    Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
    Cascade Cancer Center at Evergreen Hospital Medical Center

    Trial Locations
    Cascade Cancer Center at Evergreen Hospital Medical Center
    Olympic Medical Center
    Valley Medical Center
    CCOP - Virginia Mason Research Center
    Southwest Washington Medical Center Cancer Center
    Breast Cancer
    Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
    Harrison Bremerton Hematology and Oncology

    Trial Locations
    Harrison Bremerton Hematology and Oncology
    Columbia Basin Hematology and Oncology PLLC
    Skagit Valley Hospital
    University of Washington Medical Center
    Puget Sound Oncology Consortium
    Group Health Cooperative
    Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
    Harborview Medical Center
    Minor and James Medical PLLC
    The Polyclinic
    Swedish Medical Center-First Hill
    United General Hospital
    Cancer Care Northwest - Spokane South
    Central Washington Hospital
    Wenatchee Valley Medical Center
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes
    Providence Cancer Center at Sacred Heart Medical Center
    Spokane, Washington 99220-2555
    Leukemia
    Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant
    Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

    Trial Locations
    Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
    VA Puget Sound Health Care System
    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, de Novo Myelodysplastic Syndromes, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Juvenile Myelomonocytic Leukemia, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Splenic Marginal Zone Lymphoma, Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Multiple Myeloma, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Small Lymphocytic Lymphoma
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    Olympic Hematology and Oncology

    Trial Locations
    Olympic Hematology and Oncology
    Cascade Cancer Center at Evergreen Hospital Medical Center
    Skagit Valley Hospital Cancer Care Center
    Olympic Medical Center
    Valley Medical Center
    Fred Hutchinson Cancer Research Center
    CCOP - Virginia Mason Research Center
    Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
    Group Health Central Hospital
    Rockwood Clinic Cancer Treatment Center
    Cancer Care Northwest - North
    Madigan Army Medical Center - Tacoma
    Southwest Washington Medical Center Cancer Center
    Colorectal Cancer